<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00504036</url>
  </required_header>
  <id_info>
    <org_study_id>P060408</org_study_id>
    <nct_id>NCT00504036</nct_id>
  </id_info>
  <brief_title>Efficacy of Preoperative Intra Gastric Balloon in Morbidly Obese Patients Selected for Gastric By-pass</brief_title>
  <acronym>BIGPOM</acronym>
  <official_title>Medico Economic Evaluation of a Temporary (6 Months) Intra-gastric Balloon in Morbidly Obese Patients Before a Gastric By-pass. A Randomised Multicenter Study Comparing the Usual Strategy to Two Types of Gastric Balloon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate, during a prospective randomized medico-economic study, in morbidly obese&#xD;
      patients (BMI &gt; 45 kg/m²) selected for a laparoscopic gastric by-pass that, in comparison to&#xD;
      usual care, a temporary intra-gastric balloon (6 months) decreases medical costs and&#xD;
      peri-operative morbidity.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      On inclusion, comorbidities associated with obesity will be recorded. After recording of the&#xD;
      informed consent patients will be randomized in two groups: usual care or intra-gastric&#xD;
      balloon. In the latter, a second randomization will be performed between air-filled balloon&#xD;
      or water-filled balloon. Six months later, after withdrawal of the balloon (if required),&#xD;
      laparoscopic gastric by-pass will be performed. Thereafter, patients will be followed during&#xD;
      6 months.&#xD;
&#xD;
      On each visit, inclusion, 3 months, 6 months, surgery, 1 month and 6 months post surgery, a&#xD;
      medical and biological evaluation will be systematically performed.&#xD;
&#xD;
      The main criteria of judgement is the rate of admission in ICU during more than 24 hrs during&#xD;
      the 30 days following surgery.&#xD;
&#xD;
      The secondary criteria of judgement is: the differences in pre-operative weight loss between&#xD;
      the 2 groups, number of complications occurring during the 30 days after surgery, differences&#xD;
      in different scales of quality of life (SF36, IWQOL-lite), differences in operative time,&#xD;
      length of hospital stay, readmissions, and medical cots between the two strategies. Efficacy&#xD;
      and tolerance of each type of balloon (air-filled or water-filled) will be compared in the&#xD;
      intra-gastric balloon group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of admission in Intensive Care Units</measure>
    <time_frame>&gt; 24 hrs during the 30-day period following gastric by-pass</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in absolute weight loss</measure>
    <time_frame>at 6 months, before gastric by-pass, between the 2 strategies</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and types of complications occurring</measure>
    <time_frame>during the 30-day post-operative period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of comorbidities present</measure>
    <time_frame>after the 6-month initial period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in quality of life</measure>
    <time_frame>at the end of first 6-month period and at the end of the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in time of surgery, length of stay, readmission</measure>
    <time_frame>during the 30-day post by-pass period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in medical costs between the 2 strategies</measure>
    <time_frame>6 months before and after gastric by-pass</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">314</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>Intra-gastric balloon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive either an air-filled or water-filled intra-gastric balloon.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care will be given to the patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>inflatable intra-gastric balloon</intervention_name>
    <description>inflatable intra-gastric balloon</description>
    <arm_group_label>Intra-gastric balloon</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 and 75 years&#xD;
&#xD;
          -  Patients with morbid obesity with BMI &gt; 45 kg/m² requiring a gastric by-pass by&#xD;
             laparoscopy.&#xD;
&#xD;
          -  No efficacy of previous treatment on obesity&#xD;
&#xD;
          -  Firmed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients in whom laparoscopy is contra-indicated&#xD;
&#xD;
          -  Indication of gastric by-pass by laparoscopy retained without multidisciplinary advice&#xD;
&#xD;
          -  Morbid obesity present since less than 5 years&#xD;
&#xD;
          -  Severe associated pathology, non-related to obesity, impairing vital prognosis on a&#xD;
             short or mean time&#xD;
&#xD;
          -  Past history of gastric surgery, or gastric complication related to gastric lap-band&#xD;
&#xD;
          -  Lack of health insurance&#xD;
&#xD;
          -  Patient refusing to be followed 6 months before and after surgery&#xD;
&#xD;
          -  Drug abuse&#xD;
&#xD;
          -  Pregnancy or foreseeable pregnancy during the study&#xD;
&#xD;
          -  Patients taking anticoagulant agents or steroids&#xD;
&#xD;
          -  Patients with hiatal hernia &gt; 4 cm&#xD;
&#xD;
          -  Patients with active ulcerated esophagitis (grade C-D in Los Angeles Classification)&#xD;
&#xD;
          -  Patients with duodenal or gastric ulcer&#xD;
&#xD;
          -  Patients with gastric or esophageal varices&#xD;
&#xD;
          -  Patients with NSAIDs not taking PPI&#xD;
&#xD;
          -  Patients with bulimia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benoit Coffin, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Louis Mourier</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Fernandes M, Atallah AN, Soares BG, Humberto S, Guimarães S, Matos D, Monteiro L, Richter B. Intragastric balloon for obesity. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004931. Review.</citation>
    <PMID>17253531</PMID>
  </results_reference>
  <verification_date>October 2008</verification_date>
  <study_first_submitted>July 18, 2007</study_first_submitted>
  <study_first_submitted_qc>July 18, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2007</study_first_posted>
  <last_update_submitted>October 31, 2011</last_update_submitted>
  <last_update_submitted_qc>October 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Morbid obesity</keyword>
  <keyword>Gastric balloon</keyword>
  <keyword>Gastric by-pass</keyword>
  <keyword>Morbid obesity with BMI &gt; 45 kg/m²</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

